• LAST PRICE
    3.0000
  • TODAY'S CHANGE (%)
    Trending Down-0.1800 (-5.6604%)
  • Bid / Lots
    2.9000/ 7
  • Ask / Lots
    3.1500/ 3
  • Open / Previous Close
    3.0700 / 3.1800
  • Day Range
    Low 2.9000
    High 3.1100
  • 52 Week Range
    Low 1.1100
    High 3.5299
  • Volume
    652,824
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.18
TimeVolumeGLYC
09:32 ET93603.085
09:34 ET37413.085
09:36 ET8303.08
09:38 ET13843.06
09:39 ET32553.025
09:41 ET8003
09:43 ET52003.0004
09:45 ET11003.01
09:48 ET277782.98
09:50 ET20482.945
09:52 ET4302.94
09:54 ET6502.94
09:56 ET4002.94
09:57 ET12002.94
09:59 ET88152.95
10:01 ET269982.94
10:03 ET105432.935
10:06 ET4002.925
10:08 ET1002.925
10:10 ET18102.94
10:12 ET2002.95
10:14 ET5002.955
10:15 ET2682.96
10:17 ET91442.91
10:19 ET2002.925
10:21 ET1002.925
10:24 ET77652.96
10:26 ET14002.96
10:28 ET1002.96
10:30 ET14042.96
10:32 ET20222.96
10:33 ET43262.965
10:35 ET53002.98
10:37 ET1003
10:39 ET13332.99
10:42 ET24962.99
10:44 ET70222.99
10:46 ET27002.99
10:48 ET28002.98
10:50 ET7002.99
10:51 ET1002.995
10:53 ET314353.02
10:55 ET1003.02
10:57 ET13903.01
11:00 ET22003
11:02 ET18213
11:04 ET8002.99
11:06 ET1002.975
11:08 ET53192.975
11:09 ET29952.99
11:18 ET1002.99
11:20 ET1002.99
11:22 ET4002.99
11:24 ET4742.99
11:26 ET17002.99
11:27 ET1442.99
11:29 ET2002.99
11:31 ET14552.995
11:33 ET4002.995
11:36 ET23503.01
11:38 ET53712.99
11:40 ET1002.99
11:42 ET1002.985
11:44 ET7002.97
11:47 ET4922.965
11:51 ET6002.97
11:54 ET1002.97
11:58 ET1002.97
12:02 ET1002.97
12:03 ET1002.96
12:07 ET2002.98
12:09 ET1002.97
12:12 ET10002.9601
12:14 ET2002.965
12:18 ET2002.9671
12:20 ET4002.97
12:21 ET9002.97
12:23 ET24422.95
12:30 ET5002.95
12:36 ET1002.95
12:38 ET17012.96
12:39 ET8002.96
12:45 ET1002.96
12:48 ET10002.95
12:52 ET18352.95
12:54 ET12142.95
12:56 ET15362.96
12:57 ET1002.97
01:03 ET92232.98
01:06 ET25002.99
01:08 ET1162.975
01:10 ET53572.99
01:12 ET49033
01:14 ET3553
01:15 ET2003
01:17 ET11002.995
01:19 ET106343.02
01:21 ET35113.02
01:24 ET4003.02
01:26 ET72423.02
01:28 ET5163.02
01:30 ET311003.06
01:32 ET5003.03
01:33 ET116673.02
01:35 ET11413
01:37 ET1112.99
01:39 ET33003.005
01:42 ET3203.005
01:44 ET1002.99
01:46 ET2003.005
01:48 ET1003.005
01:51 ET1003.005
01:53 ET1003.005
01:55 ET148823.01
01:57 ET20193.015
02:00 ET17923
02:02 ET35333.01
02:04 ET8252.995
02:06 ET17003
02:08 ET19003.005
02:09 ET1003
02:11 ET3003.005
02:13 ET31123.005
02:15 ET4063
02:18 ET3003.005
02:20 ET4003
02:22 ET2003.005
02:24 ET13073.005
02:26 ET5003
02:27 ET2003.005
02:29 ET4023.005
02:31 ET57203.005
02:33 ET173053.03
02:36 ET73553.02
02:38 ET22003.02
02:40 ET12003.02
02:42 ET32273.03
02:44 ET24983.02
02:45 ET106423
02:47 ET19003.01
02:49 ET9003
02:51 ET1003.005
02:54 ET4003
02:56 ET4002.995
02:58 ET3003
03:00 ET10002.995
03:02 ET4002.995
03:03 ET139113
03:05 ET3003
03:07 ET8003.02
03:09 ET25973.005
03:12 ET223033.005
03:14 ET9003.005
03:16 ET62832.995
03:18 ET1002.995
03:20 ET4002.995
03:21 ET5002.995
03:23 ET5002.995
03:25 ET3002.995
03:27 ET6002.995
03:30 ET5002.995
03:32 ET11002.995
03:34 ET7002.995
03:36 ET5002.995
03:38 ET4002.995
03:39 ET10583
03:41 ET3002.995
03:43 ET54142.995
03:45 ET155313
03:48 ET161663.02
03:50 ET141843.01
03:52 ET82703.03
03:54 ET82033.03
03:56 ET85113.015
03:57 ET94553.015
03:59 ET134853
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLYC
GlycoMimetics Inc
193.2M
-5.1x
---
United StatesACET
Adicet Bio Inc
193.1M
-0.7x
---
United StatesALDX
Aldeyra Therapeutics Inc
192.6M
-5.1x
---
United StatesRGLS
Regulus Therapeutics Inc
188.5M
-1.8x
---
United StatesINMB
INmune Bio Inc
211.8M
-7.7x
---
United StatesMACK
Merrimack Pharmaceuticals Inc
214.6M
-178.8x
---
As of 2024-03-29

Company Information

GlycoMimetics, Inc. is a clinical-stage biotechnology company, which is focused on the discovery and development of glycomimetic drugs. It is developing a pipeline of glycomimetics, which are small molecules that mimic the structure of carbohydrates involved in biological processes, to inhibit disease-related functions of carbohydrates, such as the roles they play in inflammation, cancer, and infection. Its drug candidates include Uproleselan, GMI-1359, GMI-1687, and Galectin Antagonists. It is developing Uproleselan, a specific E-selectin inhibitor, to be used in combination with chemotherapy to treat patients with acute myeloid leukemia (AML). Its GMI-1359 targets both E-selectin and a chemokine receptor known as CXCR4. It has designed an antagonist of E-selectin, GMI-1687, that is suitable for subcutaneous administration. The Company is engaged in advancing other preclinical-stage programs, including small-molecule glycomimetic compounds that inhibit the protein galectin-3.

Contact Information

Headquarters
9708 Medical Center DriveROCKVILLE, MD, United States 20850
Phone
240-243-1201
Fax
240-243-1018

Executives

Independent Chairman of the Board
Timothy Pearson
President, Chief Executive Officer, Director
Harout Semerjian
Co-Founder, Director
Rachel King
Chief Financial Officer, Senior Vice President - Finance
Brian Hahn
Senior Vice President, Chief Commercial Officer
Bruce Johnson

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$193.2M
Revenue (TTM)
$10.0K
Shares Outstanding
64.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.17
EPS
$-0.58
Book Value
$0.60
P/E Ratio
-5.1x
Price/Sales (TTM)
19,318.0
Price/Cash Flow (TTM)
---
Operating Margin
-392,753.00%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.